Susquehanna Fundamental Investments, LLC Applied Genetic Technologies Corp Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.29 - $0.89 $27,845 - $85,457	-96,020 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.87 - $2.91 $24,627 - $38,324	13,170 Added 15.9%	96,020 $182,000
Q3 2021 Nov 15, 2021	BUY	$3.01 - $4.12 $249,378 - $341,342	82,850 New	82,850 $249,000
Q4 2020 Feb 16, 2021	SELL	$3.99 - $5.7 $92,967 - $132,810	-23,300 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.38 - $6.43 $102,054 - $149,819	23,300 New	23,300 $113,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.